Delivery Order SPE2DB20D3101-SPE2DB22FJ4G5
Award Date 4/11/22
Potential Completion Date 4/12/22
Potential Value $6.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,140.36, is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a performance period ending on July 26, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Ciprofloxacin-Dexamethasone Otic Suspension, a specialty pharmaceutical product, for a total ceiling value of $1,490.75. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $2,600.46, is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product used for medical treatment. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication Ciproflox-Dexameth Otic Suspension. The contract has a ceiling value of $1,536.62 and an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has a ceiling value of $1,105.36 and runs through June 13, 2023. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award, valued at $1,296.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension, a medical product used for various pharmaceutical applications. The contract has a completion date of July 3, 2024 and is structured as a firm fixed-price delivery order. There is no set-aside designation, indicating the contract was awarded through open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,585.63, is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 mL) to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ciproflox-Dexameth Otic Suspension 7.5 mL. The contract has a ceiling value of $1,567.17 and an ultimate completion date of December 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,704.96, is for the delivery of Ciproflox-Dexameth Otic Suspension, a medical product used for various therapeutic purposes. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, with a ceiling value of $7,892.63 and an ultimate completion date of February 6, 2024. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor with no major subcontractors listed. The...